Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Alignment of stakeholder agendas to facilitate the adoption of school-supervised asthma therapy.
Using circulating cell-free DNA to monitor personalized cancer therapy.
Decreased Expression of Retinoid X Receptors During Human and Azoxymethane-induced Colorectal Carcinogenesis in the Rat.
Disruption of crosstalk between mesenchymal stromal and tumor cells in bone marrow as a therapeutic target to prevent metastatic bone disease.
Tumor Mutation Burden-From Hopes to Doubts.
See All 20 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tumor Mutation Burden-From Hopes to Doubts.
Addeo A, Banna GL, Weiss GJ. Tumor Mutation Burden-From Hopes to Doubts. JAMA Oncol. 2019 Jul 01; 5(7):934-935.
View in:
PubMed
subject areas
Antineoplastic Agents
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Humans
Lung Neoplasms
Mutation
Survival Analysis
authors with profiles
Glen Weiss MD, MBA